Benzinga

Benzinga

Benzinga

miércoles, septiembre 02

Omega Healthcare Investors Inc

OHINYSE
Trade with Public
Trade with Public
$46.99
0.200.43%
al cierre: Sep 2, 5:00 PM EST
$46.99
N/A
After hour: 4:02 PM EST
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

Omega Healthcare Invts Analyst Price Targets

Wall Street analyst price targets and consensus rating for Omega Healthcare Invts (OHI).

Price Target Range — 13 Quarters

Analyst Consensus — 16 Analysts

6Buy
8Hold
2Sell
Consensus RatingBuy# Analysts16Avg. Consensus PT$46Upside to Avg. PT-3.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 1, 2026Wells FargoJohn KilichowskiPT CutEqual-Weight$49→$48
Aug 31, 2026BarclaysRichard HightowerPT CutUnderweight$51→$50
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Omega Healthcare Invts, Lowers Price Target to $48

Wells Fargo analyst John Kilichowski maintains Omega Healthcare Invts (NYSE:OHI) with a Equal-Weight and lowers the price target from $49 to $48.
Benzinga Newsdesk

PRO
Barclays Maintains Underweight on Omega Healthcare Invts, Lowers Price Target to $50

Barclays analyst Richard Hightower maintains Omega Healthcare Invts (NYSE:OHI) with a Underweight and lowers the price target from $51 to $50.
Benzinga Newsdesk

PRO
Mizuho Maintains Neutral on Omega Healthcare Invts, Raises Price Target to $46

Mizuho analyst Haendel St. Juste maintains Omega Healthcare Invts (NYSE:OHI) with a Neutral and raises the price target from $45 to $46.
Benzinga Newsdesk

Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields

In uncertain markets, investors turn to dividend-yielding stocks. Benzinga provides latest analyst ratings & news for high-yielding stocks.
Avi Kapoor

PRO
Citigroup Maintains Buy on Omega Healthcare Invts, Raises Price Target to $58

Citigroup analyst Nick Joseph maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and raises the price target from $52 to $58.
Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on Omega Healthcare Invts, Raises Price Target to $56

Cantor Fitzgerald analyst Richard Anderson maintains Omega Healthcare Invts (NYSE:OHI) with a Overweight and raises the price target from $52 to $56.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved